Exercise Training in Juvenile Dermatomyositis

Imagem de Miniatura
Arquivos
art_OMORI_Exercise_Training_in_Juvenile_Dermatomyositis_2012.PDF (166.9 KB)
Citações na Scopus
53
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
ROSCHEL, Hamilton
GUALANO, Bruno
Citação
ARTHRITIS CARE & RESEARCH, v.64, n.8, p.1186-1194, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. To investigate the effects of a supervised exercise training program on health parameters, physical capacity, and health-related quality of life in patients with mild and chronic juvenile dermatomyositis (DM). Methods. This was a prospective longitudinal study following 10 children with mild and chronic juvenile DM (disease duration >1 year). The exercise program consisted of twice-a-week aerobic and resistance training. At baseline and after the 12-week intervention, we assessed muscle strength and function, aerobic conditioning, body composition, juvenile DM scores, and health-related quality of life. Results. Child self-report and parent proxy-report Pediatric Quality of Life Inventory scores were improved after the intervention (-40.3%; P = 0.001 and -48.2%; P = 0.049, respectively). Importantly, after exercise, the Disease Activity Score was reduced (-26.9%; P = 0.026) and the Childhood Muscle Assessment Scale was improved (+2.5%; P = 0.009), whereas the Manual Muscle Test presented a trend toward statistical significance (+2.2%; P = 0.081). The peak oxygen consumption and time-to-exhaustion were increased by 13.3% (P = 0.001) and 18.2% (P = 0.003), respectively, whereas resting heart rate was decreased by 14.7% (P = 0.006), indicating important cardiovascular adaptations to the exercise program. Upper and lower extremity muscle strength and muscle function were also significantly improved after the exercise training (P < 0.05). Both the whole-body and the lumbar spine bone mineral apparent density were significantly increased after training (1.44%; P = 0.044 and 2.85%; P = 0.008, respectively). Conclusion. We showed for the first time that a 12-week supervised exercise program is safe and can improve muscle strength and function, aerobic conditioning, bone mass, disease activity, and health-related quality of life in patients with active and nonactive mild and chronic juvenile DM with near normal physical function and quality of life.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/2490
Referências
  1. Alexanderson H, 2007, ARTHRIT RHEUM-ARTHR, V57, P768, DOI 10.1002/art.22780
  2. Alexanderson H, 2005, CURR OPIN RHEUMATOL, V17, P164, DOI 10.1097/01.bor.0000152665.41493.49
  3. Altman RD, 2010, AM J MANAG CARE, V16, pS41
  4. Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
  5. Babatunde OO, 2012, OSTEOPOROSIS INT, V23, P109, DOI 10.1007/s00198-011-1801-0
  6. Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672
  7. Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371
  8. Bode RK, 2003, ARTHRIT RHEUM-ARTHR, V49, P7, DOI 10.1002/art.10924
  9. BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
  10. Booth FW, 2011, SCAND J MED SCI SPOR, V20, P1
  11. CARTER DR, 1992, J BONE MINER RES, V7, P137
  12. Cohen J., 1988, STAT POWER ANAL BEHA
  13. Crabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3
  14. Painelli VD, 2009, AUTOIMMUN REV, V8, P355, DOI 10.1016/j.autrev.2008.11.008
  15. Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407
  16. Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1
  17. Goulding A, 2009, BONE, V45, P455, DOI 10.1016/j.bone.2009.05.007
  18. Guadalupe-Grau A, 2009, SPORTS MED, V39, P439, DOI 10.2165/00007256-200939060-00002
  19. Gualano B, 2010, AUTOIMMUN REV, V9, P569, DOI 10.1016/j.autrev.2010.04.001
  20. Gualano B, 2010, MED SCI SPORT EXER, V42, P250, DOI 10.1249/MSS.0b013e3181b18fb8
  21. Harris-Love MO, 2003, CURR OPIN RHEUMATOL, V15, P679, DOI 10.1097/00002281-200311000-00002
  22. Kelley GA, 2011, ARTHRIT CARE RES, V63, P79, DOI 10.1002/acr.20347
  23. Klatchoian DA, 2008, J PEDIAT-BRAZIL, V84, P308, DOI [10.2223/JPED.1788, 10.1590/S0021-75572008000400005]
  24. Legg AT, 1932, PRINCIPLES PRACTICES
  25. Lovell DJ, 1999, ARTHRITIS RHEUM, V42, P2213, DOI 10.1002/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8
  26. Machado CSM, 2001, CLIN EXP RHEUMATOL, V19, pS25
  27. Maillard SM, 2005, ARTHRIT RHEUM-ARTHR, V53, P558, DOI 10.1002/art.21332
  28. Nader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016
  29. Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x
  30. Pignone Alberto, 2002, Autoimmunity Reviews, V1, P226, DOI 10.1016/S1568-9972(02)00055-1
  31. Pinto ALS, 2011, J STRENGTH COND RES, V25, P1423, DOI 10.1519/JSC.0b013e3181d6858b
  32. Rider LG, 2007, AUTOIMMUN REV, V6, P241, DOI 10.1016/j.autrev.2006.08.009
  33. Ruperto N, 2010, ARTHRIT CARE RES, V62, P1533, DOI 10.1002/acr.20280
  34. Sanudo B, 2011, J REHABIL MED, V43, P521, DOI 10.2340/16501977-0814
  35. Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C
  36. Takken T, 2005, ARTHRIT RHEUM-ARTHR, V53, P173, DOI 10.1002/art.21066
  37. Takken T, 2003, J RHEUMATOL, V30, P1075
  38. Takken T, 2008, ARTHRIT RHEUM-ARTHR, V59, P59, DOI 10.1002/art.23250
  39. Taylor A, 1997, J BONE MINER RES, V12, P652, DOI 10.1359/jbmr.1997.12.4.652

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - LIM/36